These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 2485067
1. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts. Linz W, Schölkens BA. J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S75-82. PubMed ID: 2485067 [Abstract] [Full Text] [Related]
3. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. Linz W, Schölkens BA, Han YF. J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S91-9. PubMed ID: 2438498 [Abstract] [Full Text] [Related]
4. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril. Linz W, Schölkens BA, Kaiser J, Just M, Qi BY, Albus U, Petry P. Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056 [Abstract] [Full Text] [Related]
5. Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts. Schölkens BA, Linz W. Clin Exp Hypertens A; 1988 Dec; 10(6):1259-70. PubMed ID: 2975971 [Abstract] [Full Text] [Related]
6. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia]. Schölkens BA, Linz W. Klin Wochenschr; 1991 Dec; 69 Suppl 24():1-5. PubMed ID: 1865630 [Abstract] [Full Text] [Related]
7. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist. Schölkens BA, Linz W, König W. J Hypertens Suppl; 1988 Dec; 6(4):S25-8. PubMed ID: 2853732 [Abstract] [Full Text] [Related]
9. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium. Carlsson L, Abrahamsson T. Eur J Pharmacol; 1989 Jul 18; 166(2):157-64. PubMed ID: 2792189 [Abstract] [Full Text] [Related]
10. Attenuation of reperfusion arrhythmias by selective inhibition of angiotensin-converting enzyme/kininase II in the ischemic zone: mediated by endogenous bradykinin? Shimada Y, Avkiran M. J Cardiovasc Pharmacol; 1996 Mar 18; 27(3):428-38. PubMed ID: 8907806 [Abstract] [Full Text] [Related]
11. Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectives. Schölkens BA, Linz W. Clin Physiol Biochem; 1990 Mar 18; 8 Suppl 1():33-43. PubMed ID: 2147878 [Abstract] [Full Text] [Related]
15. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Liu YH, Yang XP, Sharov VG, Sigmon DH, Sabbath HN, Carretero OA. Hypertension; 1996 Jan 18; 27(1):7-13. PubMed ID: 8591891 [Abstract] [Full Text] [Related]
18. Influence of the thromboxane synthetase inhibitor HOE 944, prostacyclin and indomethacin on reperfusion arrhythmias, cardiodynamics and metabolism in isolated ischemic rat hearts. Linz W, Lau HH, Beck G, Schökens BA. Biomed Biochim Acta; 1988 Jan 18; 47(10-11):S23-6. PubMed ID: 3073762 [Abstract] [Full Text] [Related]
19. Exacerbation of left ventricular ischemic diastolic dysfunction by pressure-overload hypertrophy. Modification by specific inhibition of cardiac angiotensin converting enzyme. Eberli FR, Apstein CS, Ngoy S, Lorell BH. Circ Res; 1992 May 18; 70(5):931-43. PubMed ID: 1314716 [Abstract] [Full Text] [Related]
20. Bradykinin accounts for improved postischemic function and decreased glutathione release of guinea pig heart treated with the angiotensin-converting enzyme inhibitor ramiprilat. Massoudy P, Becker BF, Gerlach E. J Cardiovasc Pharmacol; 1994 Apr 18; 23(4):632-9. PubMed ID: 7516015 [Abstract] [Full Text] [Related] Page: [Next] [New Search]